V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290007241 | 290005561 | 0 | 51.7 | Palliative (P) | 2014-11-11 | 2014-11-25 | Cetuximab + Radiotherapy Maint | 02 | N | 290022744 | CARBO + FLUOROURACIL |
| 290007242 | 290005561 | 1.7 | 54 | Palliative (P) | 2017-11-26 | 2017-12-08 | FEC 60 or 75 | N | N | 290022744 | PCV |
| 290007243 | 290005562 | 0 | 60.3 | Palliative (P) | 2014-06-25 | 2016-03-16 | Capecitabine + Oxaliplatin 21day | 02 | N | 290022752 | GEMCITABINE |
| 290007244 | 290005563 | 1.67 | null | Palliative (P) | 2015-10-13 | 2015-10-27 | BCG Intravesical | 2 | null | 290022755 | CAPECITABINE + OXALIPLATIN |
| 290007245 | 290007360 | 1.6 | 53.7 | Curative (C) | 2018-05-26 | 2018-05-26 | Capecitabine 35days + RT | N | N | 290022763 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290007246 | 290005565 | null | 67.55 | Palliative (P) | null | 2014-09-09 | Carboplatin + Etoposide iv&po | N | N | 290022764 | INTERAACT TRIAL |
| 290007247 | 290005566 | 1.6 | 51.7 | Curative (C) | 2015-08-07 | 2015-08-19 | Trial Unspecified | 02 | N | 290022768 | CAPECITABINE + OXALIPLATIN |
| 290007248 | 290005566 | 0 | 93 | Palliative (P) | 2015-07-06 | 2015-08-02 | CETUXIMAB + CISPLATIN + FU | 02 | N | 290022768 | CAPECITABINE |
| 290007249 | 290005567 | 1.82 | 69.2 | Palliative (P) | 2017-08-10 | 2017-08-10 | Sunitinib | 2 | N | 290022776 | SUNITINIB |
| 290007250 | 290007364 | 1.79 | null | Curative (C) | 2014-09-10 | 2014-09-20 | CAPECITABINE + RT | N | N | 290026433 | METHOTREXATE INTRATHECAL |
| 290007251 | 290007364 | 1.76 | 83.6 | Palliative (P) | 2016-01-19 | 2016-01-23 | CISPLATIN + RT | 02 | N | 290026433 | CARBO + FLUOROURACIL |
| 290007252 | 290005571 | 1.59 | null | Disease modification (D) | 2019-04-11 | 2019-04-13 | DHAP - R | null | N | 290000565 | Y-90 |
| 290007253 | 290005571 | 1.65 | 41.7 | Neo-adjuvant (N) | 2016-12-27 | 2017-01-04 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 290000565 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290007254 | 290005574 | 1.72 | 71 | Palliative (P) | 2017-06-08 | 2017-07-09 | Irinotecan | 2 | N | 290000851 | CETUXIMAB + CISPLATIN + FU |
| 290007255 | 290005575 | 1.57 | 61.2 | Palliative (P) | 2014-12-04 | 2015-01-16 | LANREOTIDE | 2 | N | 290000907 | NIVOLUMAB |
| 290007256 | 290007368 | 0 | 78.7 | Palliative (P) | 2015-05-15 | 2015-06-10 | Capecitabine + Mitomycin | 02 | N | 290001592 | CAPECITABINE |
| 290007257 | 290005579 | 1.87 | 86 | Palliative (P) | 2018-07-06 | 2018-07-12 | Capecitabine 42days + RT | 2 | N | 290001887 | REGORAFENIB |
| 290007258 | 290007369 | 1.72 | 79 | Adjuvant (A) | 2015-10-10 | 2015-10-11 | LANREOTIDE | N | N | 290001995 | SUNITINIB |
| 290007259 | 290005580 | 1.87 | 62.3 | Curative (C) | 2019-06-14 | 2019-06-23 | Capecitabine + Oxaliplatin 21day | N | N | 290002606 | CETUXIMAB + RT |
| 290007260 | 290005582 | null | 66.5 | Palliative (P) | 2018-08-28 | 2018-09-02 | Capecitabine | N | N | 290002606 | CAPECITABINE + OXALIPLATIN |
| 290007261 | 290005584 | 1.7 | null | Palliative (P) | 2016-06-18 | 2016-06-18 | Trial Unspecified | N | Y | 290003161 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 290007262 | 290005585 | 1.56 | 0 | Palliative (P) | 2015-10-22 | 2015-11-01 | Capecitabine + Oxaliplatin 21day | N | N | 290003361 | DOXORUBICIN EMBOLISATION |
| 290007263 | 290007371 | 1.69 | 60.2 | Palliative (P) | 2018-11-30 | 2018-12-07 | CISPLATIN + VINORELBINE + RT | N | N | 290004590 | CARBOPLATIN + CETUXIMAB + FU |
| 290007264 | 290007371 | null | 74.5 | Neo-adjuvant (N) | null | 2016-01-26 | Capecitabine + Mitomycin | null | null | 290004590 | BEVACIZUMAB |
| 290007265 | 290005586 | 1.9 | 53.5 | Palliative (P) | 2017-07-18 | 2017-07-27 | Capecitabine + Oxaliplatin 21day | Y | N | 290004877 | CARBOPLATIN + PACLITAXEL |
| 290007266 | 290005586 | 1.8 | null | Palliative (P) | 2014-12-06 | 2014-12-06 | Cisplatin | N | N | 290004877 | CAPECITABINE |
| 290007267 | 290008321 | 1.72 | null | Disease modification (D) | 2016-04-02 | 2016-04-10 | FLUOROURACIL + MITOMYCIN | N | N | 290006438 | STREPTOZOCIN + MDG |
| 290007268 | 290008424 | 1.71 | 69.2 | Disease modification (D) | 2016-03-20 | 2016-03-20 | Capecitabine + Cisplatin | N | N | 290006735 | CYCLOPHOSPHAMIDE + LENALIDOMIDE |
| 290007269 | 290005587 | 1.6 | 83 | Curative (C) | null | 2013-09-29 | Capecitabine | N | N | 290006785 | FLUOROURACIL + MITOMYCIN |
| 290007270 | 290005590 | 1.9 | 67.7 | Adjuvant (A) | null | 2016-10-12 | FLUOROURACIL + MITOMYCIN | N | N | 290006884 | IVADO |
| 290007271 | 290005590 | 1.59 | 74.5 | Palliative (P) | 2015-09-06 | 2015-09-07 | Bevacizumab + Irinotecan + MdG | 2 | N | 290006884 | TRIFLURIDINE + TIPIRACIL |
| 290007272 | 290005590 | 1.72 | 179 | Palliative (P) | null | 2016-08-16 | CETUXIMAB + IRINOTECAN + MDG | null | N | 290006884 | ECX |
| 290007273 | 290005592 | 1.58 | 53.4 | Palliative (P) | 2013-04-09 | 2013-04-09 | null | 02 | N | 290008136 | LANREOTIDE |
| 290007274 | 290005593 | 1.66 | null | Curative (C) | 2013-08-17 | 2013-09-10 | Capecitabine + Cisplatin | 02 | Y | 290008282 | CAPECITABINE + MITOMYCIN + RT |
| 290007275 | 290007374 | 1.56 | null | Palliative (P) | 2014-09-20 | 2014-09-20 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 290008653 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 290007276 | 290005594 | null | null | Palliative (P) | 2015-02-26 | 2015-02-27 | CETUXIMAB + IRINOTECAN + MDG | N | N | 290008739 | PEMBROLIZUMAB |
| 290007277 | 290005595 | 1.55 | 0 | Palliative (P) | 2018-10-25 | 2018-10-27 | CETUXIMAB | N | N | 290008801 | CAPECITABINE + OXALIPLATIN |
| 290007278 | 290005597 | 1.58 | 73 | Curative (C) | 2017-05-28 | 2017-06-04 | LANREOTIDE | N | N | 290008967 | FLUOROURACIL + MITOMYCIN |
| 290007280 | 290005598 | null | 55 | Not known (9) | 2017-08-14 | 2017-09-09 | CARBOPLATIN + FLUOROURACIL | 02 | N | 290010012 | LANREOTIDE |
| 290007281 | 290005600 | null | 88.75 | Curative (C) | 2018-08-08 | 2018-10-14 | CARBOPLATIN + ETOPOSIDE | N | N | 290010190 | CAPECITABINE + OXALIPLATIN |
| 290007282 | 290005601 | 1.6 | null | Curative (C) | 2016-08-04 | 2016-10-01 | Cytarabine intrathecal | 02 | N | 290010190 | MITOMYCIN |
| 290007283 | 290005602 | null | 67.2 | Neo-adjuvant (N) | 2017-05-26 | 2017-06-04 | CARBOPLATIN | N | null | 290010785 | CAPECITABINE + MITOMYCIN + RT |
| 290007284 | 290007379 | 1.7 | 56.9 | Disease modification (D) | 2018-10-06 | 2018-10-06 | Etoposide + Ifosfamide (5 days) | 02 | N | 290011095 | Y-90 |
| 290007285 | 290005606 | 1.74 | 56 | Curative (C) | 2015-12-24 | 2016-01-09 | Capecitabine 42days + RT | 02 | N | 290011395 | BRENTUXIMAB |
| 290007286 | 290005607 | null | null | Neo-adjuvant (N) | 2018-01-18 | 2018-02-02 | Cisplatin 100 + RT(H&N) 1 day | null | N | 290011395 | SUNITINIB |
| 290007287 | 290005608 | 1.6 | 41.8 | Palliative (P) | 2013-12-23 | 2013-12-30 | CARBOPLATIN + RT | 2 | N | 290012266 | OCTREOTIDE |
| 290007288 | 290005609 | 1.75 | 109 | Palliative (P) | 2014-05-24 | 2014-05-31 | Folfirinox | 2 | N | 290012272 | CARBOPLATIN |
| 290007289 | 290005610 | null | null | Adjuvant (A) | 2018-12-29 | 2018-12-31 | Cisplatin + Radiotherapy | N | N | 290013423 | CISPLATIN + RT |
| 290007290 | 290005611 | 1.56 | 0 | Curative (C) | 2017-11-20 | 2017-11-24 | CARBOPLATIN + RT | 02 | Y | 290013542 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290007291 | 290005612 | 1.78 | 90.1 | Neo-adjuvant (N) | 2017-03-10 | 2017-03-29 | null | 02 | N | 290013542 | CISPLATIN + RT |